Stockreport

Co-Founder of Acrivon Therapeutics Peter Blume-Jensen Buys 2.6% More Shares [Yahoo! Finance]

Acrivon Therapeutics, Inc.  (ACRV) 
PDF NASDAQ:ACRV ) recently shelled out US$82k to buy stock, at US$1.68 per share. Although the purchase is not a big one, increasing their shareholding by only 2.6%, it can [Read more]